<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(16)</volume><submitter>De Bari B</submitter><pubmed_abstract>Background: We evaluated the value of pre-treatment positron-emission tomography−computed tomography (PET-CT)-based radiomic features in predicting the locoregional progression-free survival (LR-PFS) of patients with inoperable or unresectable oesophageal cancer. Material and Methods: Forty-six patients were included and 230 radiomic parameters were extracted. After a principal component analysis (PCA), we identified the more robust radiomic parameters, and we used them to develop a heatmap. Finally, we correlated these radiomic features with LR-PFS. Results: The median follow-up time was 17 months. The two-year LR-PFS and PFS rates were 35.9% (95% CI: 18.9−53.3) and 21.6% (95%CI: 10.0−36.2), respectively. After the correlation analysis, we identified 55 radiomic parameters that were inclu</pubmed_abstract><journal>Cancers</journal><pagination>4043</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9406583</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?</pubmed_title><pmcid>PMC9406583</pmcid><pubmed_authors>De Bari B</pubmed_authors><pubmed_authors>Gatta R</pubmed_authors><pubmed_authors>Borg C</pubmed_authors><pubmed_authors>Mathieu P</pubmed_authors><pubmed_authors>Valentini V</pubmed_authors><pubmed_authors>Dinapoli N</pubmed_authors><pubmed_authors>Boulahdour H</pubmed_authors><pubmed_authors>Lefevre L</pubmed_authors><pubmed_authors>Boldrini L</pubmed_authors><pubmed_authors>Vernerey D</pubmed_authors><pubmed_authors>Henriques J</pubmed_authors><pubmed_authors>Falcoz A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?</name><description>Background: We evaluated the value of pre-treatment positron-emission tomography−computed tomography (PET-CT)-based radiomic features in predicting the locoregional progression-free survival (LR-PFS) of patients with inoperable or unresectable oesophageal cancer. Material and Methods: Forty-six patients were included and 230 radiomic parameters were extracted. After a principal component analysis (PCA), we identified the more robust radiomic parameters, and we used them to develop a heatmap. Finally, we correlated these radiomic features with LR-PFS. Results: The median follow-up time was 17 months. The two-year LR-PFS and PFS rates were 35.9% (95% CI: 18.9−53.3) and 21.6% (95%CI: 10.0−36.2), respectively. After the correlation analysis, we identified 55 radiomic parameters that were inclu</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-04-08T04:04:19.89Z</modification><creation>2025-02-19T00:34:12.32Z</creation></dates><accession>S-EPMC9406583</accession><cross_references><pubmed>36011035</pubmed><doi>10.3390/cancers14164043</doi></cross_references></HashMap>